Episode Details

Part 1: Pediatric Cardiovascular Health

Fetal to Pediatric Transition The cardiovascular system begins developing by postconceptual day 17. Fetal circulation relies on shunts—the foramen ovale (atria connection) and ductus arteriosus (pulmonary artery to aorta connection)—to bypass the lungs, as oxygenation occurs via the placenta. Post-birth, these shunts close. Pediatric vitals differ significantly from adults: infants have higher heart rates (90–160 bpm) and lower blood pressure, both of which normalize toward adult levels by adolescence.

Congenital Heart Disease (CHD) CHD constitutes the largest percentage of birth defects. Defects are categorized by their effect on blood flow:

• Increased Pulmonary Flow: Includes Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), and Patent Ductus Arteriosus (PDA). These involve holes or connections that allow blood to flood the lungs.

• Obstructive Disorders: Involve narrowing of vessels, such as Coarctation of the Aorta or valve stenosis, restricting blood flow.

• Decreased Pulmonary Flow: The classic example is Tetralogy of Fallot, characterized by four defects (including VSD and overriding aorta) causing cyanosis.

• Mixed Defects: Complex issues like Transposition of the Great Arteries, where the pulmonary artery and aorta are swapped.

Acquired Heart Disease Heart failure is the most common reason for admission in acquired cases. Key conditions include:

• Kawasaki Disease: An acute systemic vascular inflammation (leading cause of acquired heart disease) requiring IV immunoglobulin and aspirin.

• Infective Endocarditis: Bacterial infection of heart valves, often requiring long-term antibiotics.

• Rheumatic Fever: An autoimmune reaction to Group A strep pharyngeal infections, occurring 2–4 weeks post-infection.

Core Nursing Management Care focuses on four pillars: improving oxygenation, promoting adequate nutrition (critical due to high metabolic demand), preventing infection, and supporting family coping.

--------------------------------------------------------------------------------

Part 2: Pharmacology Spotlight — Propranolol

Drug Class and Mechanism Propranolol is a non-selective beta-blocker (Class II anti-arrhythmic). It works by competing with catecholamines at receptor sites. It blocks beta-1 receptors (heart) to lower heart rate and blood pressure, and beta-2 receptors (lungs/vascular), which can inadvertently cause bronchospasm.

Indications It is a versatile drug used for:

• Cardiac: Hypertension, angina, and arrhythmias.

• Non-Cardiac: Migraine prophylaxis, essential tremor, anxiety, and infantile hemangioma.

Critical Safety Warnings

• Boxed Warning: Do not abruptly discontinue. Stopping suddenly can exacerbate angina or precipitate myocardial infarction. Dosage must be tapered over at least 2 weeks.

• Side Effects: Bradycardia, hypotension, bronchospasm (caution in asthmatics), and masking of hypoglycemia symptoms.

Administration Guidelines

• Oral: Immediate-release tablets should be taken with food.

• Infantile Hemangioma (Hemangeol): Administer during or right after feeding to prevent hypoglycemia. Do not shake the bottle. Doses are given via oral syringe against the cheek.